These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 21752536)
1. RhoGDI2 confers gastric cancer cells resistance against cisplatin-induced apoptosis by upregulation of Bcl-2 expression. Cho HJ; Baek KE; Park SM; Kim IK; Nam IK; Choi YL; Park SH; Im MJ; Choi J; Ryu J; Kim JW; Lee CW; Kang SS; Yoo J Cancer Lett; 2011 Dec; 311(1):48-56. PubMed ID: 21752536 [TBL] [Abstract][Full Text] [Related]
2. PLCγ is required for RhoGDI2-mediated cisplatin resistance in gastric cancer. Cho HJ; Baek KE; Nam IK; Park SM; Kim IK; Park SH; Im MJ; Ryu KJ; Yoo JM; Hong SC; Kim JW; Lee CW; Yoo J Biochem Biophys Res Commun; 2011 Oct; 414(3):575-80. PubMed ID: 21986528 [TBL] [Abstract][Full Text] [Related]
3. RhoGDI2 expression is associated with tumor growth and malignant progression of gastric cancer. Cho HJ; Baek KE; Park SM; Kim IK; Choi YL; Cho HJ; Nam IK; Hwang EM; Park JY; Han JY; Kang SS; Kim DC; Lee WS; Lee MN; Oh GT; Kim JW; Lee CW; Yoo J Clin Cancer Res; 2009 Apr; 15(8):2612-9. PubMed ID: 19351766 [TBL] [Abstract][Full Text] [Related]
4. VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance. Cho HJ; Kim IK; Park SM; Baek KE; Nam IK; Park SH; Ryu KJ; Choi J; Ryu J; Hong SC; Jeong SH; Lee YJ; Ko GH; Kim J; Won Lee C; Soo Kang S; Yoo J Int J Cancer; 2014 Oct; 135(7):1553-63. PubMed ID: 24585459 [TBL] [Abstract][Full Text] [Related]
5. Proteomics-based strategy to delineate the molecular mechanisms of RhoGDI2-induced metastasis and drug resistance in gastric cancer. Cho HJ; Baek KE; Kim IK; Park SM; Choi YL; Nam IK; Park SH; Im MJ; Yoo JM; Ryu KJ; Oh YT; Hong SC; Kwon OH; Kim JW; Lee CW; Yoo J J Proteome Res; 2012 Apr; 11(4):2355-64. PubMed ID: 22364609 [TBL] [Abstract][Full Text] [Related]
6. Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia. Wu Y; McRoberts K; Berr SS; Frierson HF; Conaway M; Theodorescu D Oncogene; 2007 Feb; 26(5):765-73. PubMed ID: 16878152 [TBL] [Abstract][Full Text] [Related]
7. Rho GDP dissociation inhibitor protects cancer cells against drug-induced apoptosis. Zhang B; Zhang Y; Dagher MC; Shacter E Cancer Res; 2005 Jul; 65(14):6054-62. PubMed ID: 16024605 [TBL] [Abstract][Full Text] [Related]
8. 14-3-3σ attenuates RhoGDI2-induced cisplatin resistance through activation of Erk and p38 in gastric cancer cells. Kim IK; Park SM; Cho HJ; Baek KE; Nam IK; Park SH; Ryu KJ; Ryu J; Choi J; Hong SC; Kim JW; Lee CW; Kang SS; Yoo J Oncotarget; 2013 Nov; 4(11):2045-56. PubMed ID: 24185104 [TBL] [Abstract][Full Text] [Related]
9. RhoGDI2 as a therapeutic target in cancer. Cho HJ; Baek KE; Yoo J Expert Opin Ther Targets; 2010 Jan; 14(1):67-75. PubMed ID: 20001211 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of chemotherapeutic agents induced-apoptosis associated with activation of c-Jun N-terminal kinase 1 and caspase 3 (CPP32) in bax-transfected gastric cancer cells. Kim R; Ohi Y; Inoue H; Toge T Anticancer Res; 2000; 20(1A):439-44. PubMed ID: 10769693 [TBL] [Abstract][Full Text] [Related]
11. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer. Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of apoptosis facilitates necrosis induced by cisplatin in gastric cancer cells. Zhang LJ; Hao YZ; Hu CS; Ye Y; Xie QP; Thorne RF; Hersey P; Zhang XD Anticancer Drugs; 2008 Feb; 19(2):159-66. PubMed ID: 18176112 [TBL] [Abstract][Full Text] [Related]
13. Nitric oxide regulates cell sensitivity to cisplatin-induced apoptosis through S-nitrosylation and inhibition of Bcl-2 ubiquitination. Chanvorachote P; Nimmannit U; Stehlik C; Wang L; Jiang BH; Ongpipatanakul B; Rojanasakul Y Cancer Res; 2006 Jun; 66(12):6353-60. PubMed ID: 16778213 [TBL] [Abstract][Full Text] [Related]
14. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells. Arisan ED; Kutuk O; Tezil T; Bodur C; Telci D; Basaga H Breast Cancer Res Treat; 2010 Jan; 119(2):271-81. PubMed ID: 19238538 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells. Cho HJ; Kim JK; Kim KD; Yoon HK; Cho MY; Park YP; Jeon JH; Lee ES; Byun SS; Lim HM; Song EY; Lim JS; Yoon DY; Lee HG; Choe YK Cancer Lett; 2006 Jun; 237(1):56-66. PubMed ID: 16009487 [TBL] [Abstract][Full Text] [Related]
16. Modulation of apoptosis by endogenous Bcl-xL expression in MKN-45 human gastric cancer cells. Kondo S; Shinomura Y; Kanayama S; Higashimoto Y; Kiyohara T; Zushi S; Kitamura S; Ueyama H; Matsuzawa Y Oncogene; 1998 Nov; 17(20):2585-91. PubMed ID: 9840921 [TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas. Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of the proliferation of human gastric cancer cells SGC-7901 in vitro and in vivo using Bcl-2 siRNA. Hao JH; Gu QL; Liu BY; Li JF; Chen XH; Ji YB; Zhu ZG; Lin YZ Chin Med J (Engl); 2007 Dec; 120(23):2105-11. PubMed ID: 18167184 [TBL] [Abstract][Full Text] [Related]
19. Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis. Jiang M; Wei Q; Wang J; Du Q; Yu J; Zhang L; Dong Z Oncogene; 2006 Jul; 25(29):4056-66. PubMed ID: 16491117 [TBL] [Abstract][Full Text] [Related]
20. Cisplatin overcomes Bcl-2-mediated resistance to apoptosis via preferential engagement of Bak: critical role of Noxa-mediated lipid peroxidation. Kutuk O; Arisan ED; Tezil T; Shoshan MC; Basaga H Carcinogenesis; 2009 Sep; 30(9):1517-27. PubMed ID: 19578044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]